Company intelligence / Profile preview

HealthCare Royalty Partners II

Stamford, CT, USA

Ownership: Private
Employees: ~33
Development stage: Other

Overview

HealthCare Royalty Partners is a private investment firm leading in royalty monetization and structured debt financing for commercial-stage and near-commercial-stage biopharma assets; recent acquisition by KKR is intended to expand healthcare investing capabilities. Manages ~$3 billion in assets with a portfolio spanning more than 55 products and 10+ therapeutic areas.

Industry: Investors

Partnerships

Multiple undisclosed partnerships across pharmaceutical and biotech sectors (portfolio includes royalties from products marketed by major pharma companies such as Vertex, GSK, Biogen, AbbVie, Pfizer, Astellas, Johnson & Johnson, Novartis, Roche, and others via structured finance deals)

Beyond the preview

Go deeper on HealthCare Royalty Partners II.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HealthCare Royalty Partners II.

Explore the full profile